Actavis sells Bulgarian plant
This article was originally published in Scrip
Executive Summary
Actavishas signed a letter of intent to sell its Bulgarian plant, Balkanpharma-Razgrad, to Antibiotic-Razgrad. The Icelandic firm is planning to sign a contract manufacture agreement with Antibiotic-Razgrad after the deal, which is subject to regulatory approval, and is expected to be closed at the beginning of next year.